Related Experiment Video
Updated: Jul 19, 2026

Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens
Published on: October 25, 2019
Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental
Dario Caronzolo1, Valeria Lucini, Marilou Pannacci
1Department of Pharmacology, Chemotherapy, and Toxicology, University of Milan, Milan, Italy. francesco.scaglione@unimi.it
Abstract:
Chlamydophila pneumoniae is a pathogen that is involved in acute and chronic respiratory infections and that is associated with asthma and coronary artery diseases. In this study, we evaluated the effects of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, against experimental infections caused by C. pneumoniae. Moreover, we investigated the relationships between C. pneumoniae and alpha(v)beta(3) integrin functions in order to explain the possible mechanism of action of PEX both in vitro and in vivo. For the in vitro experiments, HeLa cells were infected with C. pneumoniae and treated with either PEX or azithromycin. The results obtained with PEX were not significantly different (P > 0.05) from those achieved with azithromycin. Similar results were also obtained in a lung infection model. Male C57BL/J6 mice inoculated intranasally with 10(6) inclusion-forming units of C. pneumoniae were treated with either PEX or azithromycin plus rifampin. Infected mice treated with PEX showed a marked decrease in C. pneumoniae counts versus those for the controls; this finding did not differ significantly (P > 0.05) from the results observed for the antibiotic-treated group. Integrin alpha(v)beta(3) plays an important role in C. pneumoniae infection. Blockage of integrin activation led to a significant inhibition of C. pneumoniae infection in HeLa cells. Moreover, CHO(DHFR) alpha(v)beta(3)-expressing cells were significantly (P < 0.001) more susceptible to C. pneumoniae infection than CHO(DHFR) cells. These results offer new perspectives on the treatment of C. pneumoniae infection and indicate that alpha(v)beta(3) could be a promising target for new agents developed for activity against this pathogen.
Insights
PEX effectively treats Chlamydophila pneumoniae infections by targeting alpha(v)beta(3) integrin. This pathogen is linked to respiratory issues and heart disease, making PEX a potential new therapeutic strategy.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Chlamydophila pneumoniae is a significant pathogen implicated in acute and chronic respiratory infections.
- This bacterium is also associated with the development of asthma and coronary artery diseases.
- Understanding the pathogen's interaction with host cell receptors is crucial for developing effective treatments.
Purpose of the Study:
- To evaluate the efficacy of PEX, a metalloproteinase fragment, against experimental Chlamydophila pneumoniae infections.
- To investigate the role of alpha(v)beta(3) integrin in C. pneumoniae infection.
- To elucidate the mechanism of action of PEX in vitro and in vivo.
Main Methods:
- In vitro experiments involved infecting HeLa cells with C. pneumoniae and treating with PEX or azithromycin.
- In vivo studies utilized a mouse lung infection model, treating intranasally inoculated mice with PEX or antibiotics.
- Cell susceptibility assays were performed using cells expressing alpha(v)beta(3) integrin.
Main Results:
- PEX demonstrated comparable efficacy to azithromycin in vitro and in vivo models of C. pneumoniae infection.
- Treatment with PEX significantly reduced C. pneumoniae counts in infected mice.
- Alpha(v)beta(3) integrin plays a critical role in C. pneumoniae infection, with blockage inhibiting pathogen entry.
- Cells overexpressing alpha(v)beta(3) integrin were significantly more susceptible to infection.
Conclusions:
- PEX is a promising agent for treating Chlamydophila pneumoniae infections.
- Alpha(v)beta(3) integrin represents a viable therapeutic target for novel anti-C. pneumoniae agents.
- These findings open new avenues for managing infections caused by this pathogen.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Bacterial Phylum Chlamydiae
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.

